81 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
components in a full set of general-purpose financial statements.
The Company’s other comprehensive income for the year ended December 31, 2021 … 19, 2021, the Company entered into a lease agreement for a manufacturing plant space for the purpose of manufacturing AllocetraTM to support ongoing
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
listing of a securities depository on that date. See below “How You Can Vote.”
Purpose of the Annual General Meeting
At the Meeting, shareholders
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
31 Mar 23
Report of Foreign Private Issuer
4:30pm
”. This statement establishes standards for the reporting and display of comprehensive income (loss) and its components in a full set of general-purpose … .
On September 19, 2021, the Company entered into a lease agreement for a manufacturing plant space for the purpose of manufacturing AllocetraTM to support
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
affiliates and any unconsolidated entity, including, but not limited to, any structured finance, special purpose or limited purpose entity (each, an “Off … of any proceeding for any such purpose; and it will promptly use its commercially reasonable efforts to prevent the issuance of any stop order
424B5
zrif7ckt6a1b
30 Dec 22
Prospectus supplement for primary offering
4:01pm
6-K
EX-99.1
d61mk3p16gmfjxaqodcy
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
F-3
kwiuijh
29 Apr 22
Shelf registration (foreign)
8:14am
6-K
EX-99.2
yl5cc9orzd2h zamr
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
6-K
EX-99.1
xra u04fxqqp2fo
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
6-K
EX-99.1
eidw6vhxb8y2xibcw
9 Aug 21
Enlivex Announces Second Quarter 2021 Financial Results and Provides a Business Update
8:00am
S-8
EX-5.1
zlvznn1 4o
4 Jun 21
Registration of securities for employees
4:16pm
S-8
gv41mk6jvx6 3hkyur
4 Jun 21
Registration of securities for employees
4:16pm
6-K
EX-5.1
jw1j5fqqgnjejudm
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-1.1
s8dq5 z8p2z52xf
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-10.1
wov0l
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
0n3sx
10 Feb 21
Prospectus supplement for primary offering
5:22pm
F-3MEF
EX-5.1
bhmwnn0ubiq16hcq
9 Feb 21
Registration statement to add securities to prior F-3 registration
9:40pm